Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Bibliographic Details
Main Authors:	Salaheldin Ahmed, Abdulla Ahmed, Göran Rådegran
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1002/pul2.12340

Similar Items

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
by: Abdulla Ahmed, et al.
Published: (2023-04-01)

Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
by: Abdulla Ahmed, et al.
Published: (2023-10-01)

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
by: Mattias Arvidsson, et al.
Published: (2023-07-01)

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
by: Bodil Ivarsson, et al.
Published: (2019-02-01)

Elevated plasma WIF‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
by: Kriss Kania, et al.
Published: (2022-12-01)

Plasma tumour necrosis factor‐alpha‐related proteins in prognosis of heart failure with pulmonary hypertension
by: Adam Engel Sällberg, et al.
Published: (2023-12-01)

Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
by: Sara Helleberg, et al.
Published: (2022-08-01)

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
by: Mattias Arvidsson, et al.
Published: (2022-01-01)

Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension.
by: João Victor Rolim, et al.
Published: (2018-01-01)

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Raymond L. Benza, et al.
Published: (2022-10-01)

Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: A Swedish single‐center study
by: Janica Kallonen, et al.
Published: (2023-04-01)

Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms
by: Mona Lichtblau, et al.
Published: (2023-12-01)

Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
by: Habib Bouzina, et al.
Published: (2020-06-01)

Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: N. A. Tsareva, et al.
Published: (2016-12-01)

Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension
by: Hideo Tsubata, et al.
Published: (2023-04-01)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
by: Fotini Ampatzidou, et al.
Published: (2023-07-01)

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease
by: HUANG Shenshen, et al.
Published: (2023-01-01)

Chronic thromboembolic pulmonary hypertension
by: Isabelle Opitz, et al.
Published: (2018-12-01)

CARDIOPULMONARY EXCERSISE TESTING IN RISK STRATIFICATION IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: I. N. Taran, et al.
Published: (2017-12-01)

Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension
by: Keisuke Miwa, et al.
Published: (2022-08-01)

Giant Pulmonary Artery Thrombotic Material, Due to Chronic Thromboembolic Pulmonary Hypertension, Mimics Pulmonary Artery Sarcoma
by: Helen Triantafyllidi, et al.
Published: (2021-09-01)

Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
by: Janica Kallonen, et al.
Published: (2022-04-01)

Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension
by: Ioanna Mitrouska, et al.
Published: (2022-01-01)

Chronic Thromboembolic Pulmonary Hypertension: An Update
by: Barbara Ruaro, et al.
Published: (2022-01-01)

Pulmonary arterial compliance and exercise capacity after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
by: Romain Sermet, et al.
Published: (2023-03-01)

STRUCTURAL CHANGES OF THE PULMONARY ARTERIES AFTER BALLOON PULMONARY ANGIOPLASTY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: S. Y. Yarovoy, et al.
Published: (2020-12-01)

Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension
by: Barbro Kjellström, et al.
Published: (2022-10-01)

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic
by: Maria Wieteska-Miłek, et al.
Published: (2021-09-01)

Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America
by: Mauricio Orozco‐Levi, et al.
Published: (2022-01-01)

Pulmonary arterial wedge pressure increase during exercise in patients diagnosed with pulmonary arterial or chronic thromboembolic pulmonary hypertension
by: Julian Müller, et al.
Published: (2023-09-01)

2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension
by: S. N. Avdeev, et al.
Published: (2022-01-01)

A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension
by: Maria Anna Bazmpani, et al.
Published: (2018-04-01)

Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
by: Habib Bouzina, et al.
Published: (2018-11-01)

THE ROLE OF RADIATION DIAGNOSTIC TECHNIQUES IN THE DIAGNOSIS OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
by: E. A. Mershina, et al.
Published: (2016-07-01)

Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry
by: J. Minhas, et al.
Published: (2022-04-01)

Balloon Pulmonary Angioplasty for Takayasu Arteritis and Peripheral Pulmonary Artery Stenosis Mimicking Chronic Thromboembolic Pulmonary Hypertension
by: Shigefumi Fukui, et al.
Published: (2022-11-01)

Change in health‐related quality of life at early follow‐up in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
by: Bodil Ivarsson, et al.
Published: (2024-01-01)

Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases
by: Viviane P. Sprecher, et al.
Published: (2020-11-01)

Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension
by: Zhiwei Zhai, et al.
Published: (2023-04-01)

Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
by: Barbara Ruaro, et al.
Published: (2022-08-01)